Epizyme Inc (EPZM) Insider Trading
- $81,308,409.37
- $44,581,576.74
- April 11, 2022
- Robert A Copeland
Trader Name | Date | Title | Amount | Price | Type | Total Value |
---|---|---|---|---|---|---|
April 11, 2022 | Insider | 2,741 | $0.90 | Sell | $2,466.90 | |
Feb. 7, 2022 | Insider | 222 | $1.50 | Sell | $333.00 | |
Feb. 2, 2022 | Insider | 2,639 | $1.37 | Sell | $3,615.43 | |
Jan. 31, 2022 | Director | 22,666,667 | $1.50 | Buy | $34,000,000.50 | |
Jan. 26, 2022 | Insider | 2,922 | $2.02 | Sell | $5,902.44 | |
Dec. 6, 2021 | Insider | 1,780 | $2.93 | Sell | $5,215.40 | |
April 5, 2021 | Insider | 2,029 | $8.80 | Sell | $17,855.20 | |
March 25, 2021 | CEO | 10,328 | $7.85 | Sell | $81,074.80 | |
March 25, 2021 | Director | 28,231 | $7.98 | Buy | $225,283.38 | |
Feb. 4, 2021 | CEO | 3,890 | $11.21 | Sell | $43,606.90 | |
Feb. 4, 2021 | CFO | 1,021 | $11.21 | Sell | $11,445.41 | |
Feb. 4, 2021 | Insider | 969 | $11.21 | Sell | $10,862.49 | |
Jan. 25, 2021 | CEO | 6,069 | $11.41 | Sell | $69,247.29 | |
Jan. 25, 2021 | Insider | 2,872 | $11.41 | Sell | $32,769.52 | |
Dec. 3, 2020 | Insider | 2,522 | $13.54 | Sell | $34,147.88 | |
Nov. 11, 2020 | Director | 5,000 | $12.07 | Buy | $60,350.00 | |
Sept. 3, 2020 | Insider | 971 | $12.77 | Sell | $12,399.67 | |
June 26, 2020 | CFO | 1,805 | $16.15 | Sell | $29,150.75 | |
June 26, 2020 | Insider | 317 | $16.15 | Sell | $5,119.55 | |
June 26, 2020 | Director | 62,019 | $16.03 | Buy | $994,164.57 | |
June 26, 2020 | CEO | 4,773 | $16.15 | Sell | $77,083.95 | |
June 18, 2020 | Insider | 112,003 | $21.24 | Sell | $2,378,943.72 | |
June 18, 2020 | CEO | 20,000 | $22.00 | Sell | $440,000.00 | |
March 25, 2020 | Insider | 212 | $15.28 | Sell | $3,239.36 | |
March 25, 2020 | CEO | 3,285 | $15.28 | Sell | $50,194.80 | |
March 25, 2020 | CFO | 1,243 | $15.28 | Sell | $18,993.04 | |
March 3, 2020 | Insider | 996 | $22.18 | Sell | $22,091.28 | |
Jan. 27, 2020 | Insider | 2,630 | $20.44 | Sell | $53,757.20 | |
Jan. 27, 2020 | CEO | 6,074 | $20.44 | Sell | $124,152.56 | |
Jan. 24, 2020 | Insider | 1,843 | $24.64 | Sell | $45,411.52 | |
Jan. 24, 2020 | CEO | 3,002 | $24.62 | Sell | $73,909.24 | |
June 26, 2019 | Director | 104,944 | $13.08 | Sell | $1,372,667.52 | |
June 13, 2019 | Insider | 1,185 | $12.10 | Sell | $14,338.50 | |
June 13, 2019 | CEO | 2,074 | $12.10 | Sell | $25,095.40 | |
Oct. 5, 2018 | Director | 416,667 | $9.00 | Buy | $3,750,003.00 | |
Feb. 5, 2018 | COO | 72,264 | $16.63 | Sell | $1,201,750.32 | |
Oct. 24, 2017 | Insider | 15,000 | $16.44 | Sell | $246,600.00 | |
Sept. 25, 2017 | Insider | 15,000 | $16.81 | Sell | $252,150.00 | |
Sept. 18, 2017 | Director | 200,000 | $15.25 | Buy | $3,050,000.00 | |
Aug. 24, 2017 | Insider | 15,000 | $15.68 | Sell | $235,200.00 | |
July 24, 2017 | Insider | 15,000 | $13.44 | Sell | $201,600.00 | |
June 30, 2017 | CFO | 3,024 | $15.50 | Sell | $46,872.00 | |
June 26, 2017 | Insider | 15,000 | $14.87 | Sell | $223,050.00 | |
June 6, 2017 | Insider | 2,500 | $13.45 | Sell | $33,625.00 | |
May 25, 2017 | Insider | 15,000 | $16.11 | Sell | $241,650.00 | |
May 2, 2017 | Insider | 5,000 | $17.44 | Sell | $87,200.00 | |
April 4, 2017 | Insider | 5,000 | $16.36 | Sell | $81,800.00 | |
March 31, 2017 | CFO | 2,013 | $17.09 | Sell | $34,402.17 | |
Jan. 9, 2017 | CFO | 1,013 | $12.04 | Sell | $12,196.52 | |
Dec. 9, 2016 | CFO | 1,013 | $11.03 | Sell | $11,173.39 |
Insiders are both buying and selling Epizyme Inc stock.
The insider traders at Epizyme Inc are: Robert A Copeland, Andrew E Singer, Peter Tai-Ching Ho, Shefali Agarwal, Robert B Bazemore, David M Mott, Joseph Beaulieu, Robert Copeland, Robert J Gould, Robert A. Copeland, Matthew Ros, Eric Hedrick, Jason Rhodes, Paolo Tombesi, Robert B. Bazemore, Robert Gould, Robert J. Gould, Jason P Rhodes, Jeffery Kutok, Carl Goldfischer, Bay City Capital Llc, Venture Fund I L.P. Astellas, Andrew E. Singer, Bay City Capital Fund V Co-Inv, Celgene European Investment Co, M James Barrett, Pablo G Legorreta, Ryan D Drant, and Stephen Garbacz
The most active insider trader at Epizyme Inc is Robert A Copeland with 14 trades.
Bay City Capital Llc has sold the most Epizyme Inc stock with a total value of $26,515,310.68.
Pablo G Legorreta has bought the most Epizyme Inc stock with a total value of $68,000,001.00.
The most recent insider trade for Epizyme Inc was on April 11, 2022.
The single biggest insider buy for Epizyme Inc was from Pablo G Legorreta with a total value of $34,000,000.50 on Jan. 31, 2022.
The single biggest insider sell for Epizyme Inc was from Bay City Capital Llc with a total value of $12,459,310.68 on Aug. 25, 2014.